JULIE CAMP: Open Payments
NPI 1891018792 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 17 payments from 11 companies in 2025. Trend: 2023 $51 · 2024 $238 · 2025 $491
Food & beverage: $391Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $138 |
| Lilly USA, LLC | 4 | $108 |
| Ardelyx, Inc. | 2 | $58 |
| Enterra Medical, Inc. | 1 | $40 |
| ABBVIE INC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $28 |
| Braintree Laboratories, Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: TREMFYA, OMVOH, IBSRELA, DUPIXENT, SUTAB, VEGZELMA, XIFAXAN, LINZESS.
Industry payments across MO — which companies pay providers there.
